Ioannidis, Paul

Olivia Newton-John Cancer Research Institute

1 paper on CoChatORCID 0000-0002-1003-7478

Most cited papers

Verified
PLX8394, a new generation BRAF inhibitor, selectively inhibits BRAF in colonic adenocarcinoma cells and prevents paradoxical MAPK pathway activation
Tutuka, C. S. A., Andrews, M. C., Mariadason, J. M., Ioannidis, P., Hudson, C., Cebon, J., & Behren, A. (2017) · Molecular Cancer
Melanoma and MAPK PathwaysColorectal Cancer Treatments and Studies
Cited by 58

Go further with a free account

Verify every reference, keep papers in a library, and ask questions across them.

Sign up - it is free